Skip to content
Peptigraph home

Semaglutide for Depression: What the Evidence Shows

What human and animal studies show about Semaglutide for depression, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGLP-1 agonistUpdated
Strongest evidence
Human observational
Human studies
2
with an outcome for depression, in our evidence file (PubMed search, 2 Oct 2026)
Animal studies
None found
with an outcome for depression, in our evidence file (PubMed search, 2 Oct 2026)
Studies we summarised
2
with an outcome for depression

Evidence for depression

Each row is an outcome related to depression from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

Semaglutide for depression: outcomes in published studies
OutcomeResultStudy typeSource
Neuropsychiatric safetySemaglutide was not associated with higher 12-month risk of adverse neuropsychiatric outcomes versus other antidiabetic drugs.Human observationalEClinicalMedicine 2024, PMID 39764175
Depression, anxiety and suicidal behaviorThis cohort study found 195% higher risk of major depression, 108% higher risk of anxiety and 106% higher risk of suicidal behavior in patients on GLP-1 RAs; observational and conflicts with other cohort data.Human observationaln = 162253Scientific reports 2024, PMID 39424950

Semaglutide and depression are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 2 Oct 2026). Grades follow our evidence scale.

How strong is it?

Strongest evidence:Human observational evidence, 3 of 4EClinicalMedicine 2024, PMID 39764175

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Other peptides people research for depression

TirzepatideSelank
All peptides for depression, compared

Common questions

Does Semaglutide help with depression?

The strongest study we summarise for depression is human observational evidence, across 2 studies with an outcome for depression. That is not proof it works in people.

Is Semaglutide approved for depression?

Semaglutide is FDA approved (Ozempic, Wegovy, Rybelsus). Which conditions that approval covers is set by the label; use for anything else is off-label.

What is the best peptide for depression?

There is no single answer. Our depression overview compares each candidate by evidence grade and legal status rather than by popularity.

More on Semaglutide

DosageDoses used in published studies, with the source for each.CalculatorVial, water and dose to syringe units.Side effectsWhat labels and studies report, and what is unknown.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.Legal statusFDA, compounding and WADA status with dates.

Sources

  1. 112-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study.EClinicalMedicine · 2024PMID 39764175Accessed 2 Oct 2026
  2. 2The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy.Scientific reports · 2024PMID 39424950Accessed 2 Oct 2026

Found an error? Report a correction.